TrialNature communications2022

A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer.

Choong-Kun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.